Chromatin/Epigenetics

Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
-   A4151 ZM 39923 HClTarget: JAKSummary: JAK3 inhibitor,potent and selective A4151 ZM 39923 HClTarget: JAKSummary: JAK3 inhibitor,potent and selective
-   A4488 Anacardic acidTarget: Histone Acetyltransferases (HATs)Summary: HAT inhibitor A4488 Anacardic acidTarget: Histone Acetyltransferases (HATs)Summary: HAT inhibitor
-   A8808 ME0328Target: PARPSummary: PARP inhibitor,potent and selective A8808 ME0328Target: PARPSummary: PARP inhibitor,potent and selective
-   B4949 WDR5 0103Summary: WD repeat-containing protein 5 (WDR5) antagonist B4949 WDR5 0103Summary: WD repeat-containing protein 5 (WDR5) antagonist
-   B6184 BI-9564Summary: BRD9/7 specific inhibitor B6184 BI-9564Summary: BRD9/7 specific inhibitor
-   C3898 Cantharidic Acid (sodium salt)Summary: PP1 and PP2A inhibitor C3898 Cantharidic Acid (sodium salt)Summary: PP1 and PP2A inhibitor
-   A4150 WHI-P154Target: VEGFR|Src|EGFR|JAKSummary: JAK3 inhibitor A4150 WHI-P154Target: VEGFR|Src|EGFR|JAKSummary: JAK3 inhibitor
-   A4108 Resminostat (RAS2410)1 CitationSummary: Potent HDAC inhibitor A4108 Resminostat (RAS2410)1 CitationSummary: Potent HDAC inhibitor
-   A8601 Tankyrase Inhibitors (TNKS) 49Target: TankyrasesSummary: Tankyrase inhibitor A8601 Tankyrase Inhibitors (TNKS) 49Target: TankyrasesSummary: Tankyrase inhibitor
-   B4948 UNC 2400Summary: negative control of UNC1999 B4948 UNC 2400Summary: negative control of UNC1999
